“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) occurs when fat accumulates in the liver even without excessive alcohol intake. Among the current therapeutic approaches for NAFLD, lifestyle modification with dietary changes and regular exercise is the mainstay treatment. With the rise of intestinal microe...

Full description

Bibliographic Details
Main Authors: Kangxiao Guo, Sisheng Xu, Zhaofeng Zeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1050709/full
_version_ 1811322007146463232
author Kangxiao Guo
Sisheng Xu
Zhaofeng Zeng
author_facet Kangxiao Guo
Sisheng Xu
Zhaofeng Zeng
author_sort Kangxiao Guo
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) occurs when fat accumulates in the liver even without excessive alcohol intake. Among the current therapeutic approaches for NAFLD, lifestyle modification with dietary changes and regular exercise is the mainstay treatment. With the rise of intestinal microecology, regulation of the “liver–gut” axis can be an effective treatment for NAFLD. This review aimed to assess the modulation of the liver–gut microbiota axis with traditional Chinese medicine (TCM) as a therapeutic approach to NAFLD and further explored its application in the newly discovered therapeutic avenues beyond NAFLD treatment.
first_indexed 2024-04-13T13:27:36Z
format Article
id doaj.art-ddbc6894b5074c8faf99c814f217899b
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T13:27:36Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-ddbc6894b5074c8faf99c814f217899b2022-12-22T02:45:04ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-11-011310.3389/fendo.2022.10507091050709“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver diseaseKangxiao GuoSisheng XuZhaofeng ZengNon-alcoholic fatty liver disease (NAFLD) occurs when fat accumulates in the liver even without excessive alcohol intake. Among the current therapeutic approaches for NAFLD, lifestyle modification with dietary changes and regular exercise is the mainstay treatment. With the rise of intestinal microecology, regulation of the “liver–gut” axis can be an effective treatment for NAFLD. This review aimed to assess the modulation of the liver–gut microbiota axis with traditional Chinese medicine (TCM) as a therapeutic approach to NAFLD and further explored its application in the newly discovered therapeutic avenues beyond NAFLD treatment.https://www.frontiersin.org/articles/10.3389/fendo.2022.1050709/full“liver–gut” axisintestinal microorganismstraditional Chinese medicineNAFLDtarget
spellingShingle Kangxiao Guo
Sisheng Xu
Zhaofeng Zeng
“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
Frontiers in Endocrinology
“liver–gut” axis
intestinal microorganisms
traditional Chinese medicine
NAFLD
target
title “Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
title_full “Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
title_fullStr “Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
title_full_unstemmed “Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
title_short “Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
title_sort liver gut axis a target of traditional chinese medicine for the treatment of non alcoholic fatty liver disease
topic “liver–gut” axis
intestinal microorganisms
traditional Chinese medicine
NAFLD
target
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1050709/full
work_keys_str_mv AT kangxiaoguo livergutaxisatargetoftraditionalchinesemedicineforthetreatmentofnonalcoholicfattyliverdisease
AT sishengxu livergutaxisatargetoftraditionalchinesemedicineforthetreatmentofnonalcoholicfattyliverdisease
AT zhaofengzeng livergutaxisatargetoftraditionalchinesemedicineforthetreatmentofnonalcoholicfattyliverdisease